Home » Topics » BioWorld Science

BioWorld Science
RSS

BioTheryX presents new compounds for cancer

Jan. 3, 2020

Chiesi Farmaceutici identifies ROCK1 and ROCK2 inhibitors

Jan. 3, 2020

Cadila Healthcare divulges new antimycobacterial compounds

Jan. 3, 2020

Celgene presents first-in-human data for CC-90009

Jan. 3, 2020

JNJ-7706621 reverses resistance to CD37-targeted radioimmunotherapy in DLBCL

Jan. 3, 2020

ZBP1 as a new therapeutic target in multiple myeloma

Jan. 3, 2020

Viral infection may be second hit for familial ALS

Jan. 3, 2020

PPARgamma controls antifibrotic network

Jan. 3, 2020

CAR-T therapy as powerful salvage approach in patients with R/R AL with TP53 alterations

Jan. 3, 2020

U.S. researchers present novel coagulation factor VIIa chimera for hemophilia patients

Jan. 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...